COA Available
GLP-3 R
Triple GLP-3/GIP/Glucagon Receptor Agonist
Next-generation triple receptor agonist for comprehensive metabolic support and superior weight management.
Dosage
1–2.5 mg once weekly
Half-Life
~5–7 days
MW
4397.18 g/mol
Select Size
Certificate of Analysis Available
Every batch of GLP-3 R includes a full third-party COA documenting purity, potency, and quality.
Research Benefits
- Superior weight reduction
- Enhanced glucose control
- Increased metabolic rate
- Reduced appetite
- Improved cardiovascular markers
- Sustained metabolic benefits
For research use only. Not for human consumption. Must be 18+ to purchase.
About GLP-3 R
GLP-3 R is a novel triple receptor agonist that simultaneously activates GLP-3, GIP, and glucagon receptors. This multi-targeted approach provides synergistic effects on glucose metabolism, appetite regulation, and energy expenditure. Clinical research demonstrates greater weight reduction compared to dual agonists, with average reductions exceeding 20% of body weight.